Menstrual cycle phase, menopausal transition stage, self-reports of premenstrual syndrome and symptom severity: observations from the Seattle Midlife Women's Health Study. Issue 11 (2nd November 2022)

• Record Type: Journal Article
• Authors: Mitchell, Ellen Sullivan; Woods, Nancy Fugate
• Is Part Of: Menopause. Volume 29:Issue 11(2022)
• Page Start: 1269
• Page End: 1278
• Publication Date: 2022-11-02
• Subjects: Current PMS -- Cycle phase effect -- Dysphoric mood symptoms -- Insomnia symptoms -- Menopausal transition -- Neuromuscular symptoms -- Reproductive aging stages -- Somatic symptoms -- Symptom cyclicity -- Symptom severity -- Vasomotor symptoms; Menopause -- Periodicals; 618.175005
• DOI: 10.1097/GME.0000000000002068
• Languages: English
• ISSNs: 1072-3714

Abstract

Abstract : Dysphoric mood, neuromuscular symptoms, and somatic symptoms exhibit cyclicity and are influenced by current premenstrual syndrome, but not vasomotor or insomnia symptoms. Late reproductive stage and early menopausal transition stages do not have significant effects on the five symptom groups. Abstract: Objective: The aim of this study was to determine the effects of menstrual cycle phases (postmenses and premenses), self-report of premenstrual syndrome (PMS), late reproductive stages (LRS1 and LRS2), and early menopausal transition (EMT) stage (Stages of Reproductive Aging Workshop [STRAW]) on severity of five symptom groups. Methods: A subset of Seattle Midlife Women's Health Study participants (n = 290) in either LRS1 or LRS2 or EMT (STRAW+10 criteria) provided daily symptom data for at least one full menstrual cycle during the first year of the study and reported current PMS. Symptom severity was rated (1-4, least to most severe) in the daily diary for five symptom groups (dysphoric mood, neuromuscular, somatic, vasomotor, and insomnia) identified earlier with the same sample ( Maturitas 1996;25:1-10). A three-way analysis of variance was used to test for within- and between-participants effects on symptom severity. Results: Stage had no effect on severity for any of the five symptom groups. Dysphoric mood and neuromuscular and somatic symptom severity (but not vasomotor or insomnia severity) differed significantly across menstrual cycle phases, increasing from postmenses to premenses. Current PMS and premenses cycle phase had significant interactive effects on dysphoric mood and neuromuscular symptoms, but there were no significant interaction effects on somatic, vasomotor, or insomnia symptom severity. Conclusions: Dysphoric mood, neuromuscular, and somatic symptoms exhibit cyclicity and are influenced by current PMS. Late reproductive stages and EMT stage do not have significant effects on the five symptom groups. Vasomotor or insomnia symptoms do not exhibit significant cyclicity from postmenses to premenses and are not affected by current PMS. Future studies of symptom cyclicity and reproductive aging including daily symptom data across an entire menstrual cycle in samples including women in late menopausal transition stage are essential to capture the effects of both cyclicity and self-reported PMS to capture symptom severity reports at their peak.